HC Wainwright Cuts United States Antimony (NYSE:UAMY) Price Target to $9.25

United States Antimony (NYSE:UAMY) had its price target reduced by HC Wainwright from $11.75 to $9.25 in a research note issued to investors on Wednesday, MarketBeat reports. They currently have a buy rating on the stock.

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of United States Antimony in a research report on Wednesday, June 17th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $10.12.

United States Antimony Trading Up 3.3%

Shares of NYSE:UAMY opened at $5.51 on Wednesday. The company has a 50-day moving average price of $6.46 and a 200-day moving average price of $8.23. The company has a market cap of $825.43 million, a price-to-earnings ratio of -42.42 and a beta of 0.39. United States Antimony has a 12 month low of $3.93 and a 12 month high of $19.71.

Insider Activity

In related news, Director Jon R. Marinelli acquired 12,500 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was bought at an average cost of $7.45 per share, for a total transaction of $93,125.00. Following the purchase, the director owned 12,500 shares in the company, valued at $93,125. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. KBC Group NV bought a new stake in United States Antimony during the 1st quarter valued at approximately $31,000. Meeder Asset Management Inc. purchased a new position in shares of United States Antimony in the fourth quarter worth $35,000. Harbour Investments Inc. lifted its holdings in shares of United States Antimony by 106.2% in the fourth quarter. Harbour Investments Inc. now owns 7,962 shares of the company’s stock worth $40,000 after buying an additional 4,101 shares in the last quarter. Geneos Wealth Management Inc. lifted its holdings in shares of United States Antimony by 17.9% in the first quarter. Geneos Wealth Management Inc. now owns 9,892 shares of the company’s stock worth $86,000 after buying an additional 1,500 shares in the last quarter. Finally, Focus Partners Wealth bought a new position in shares of United States Antimony during the third quarter worth $62,000. Institutional investors own 9.49% of the company’s stock.

About United States Antimony

United States Antimony Corporation is a specialized mining and chemical company focused primarily on the production and processing of antimony and antimony-based compounds. The company operates its own extraction and milling facilities to recover antimony metal and antimony trioxide, which serve as critical raw materials in industries such as flame retardants for plastics and textiles, catalysts for chemical processes, and additives for glass and ceramics. In addition to antimony, United States Antimony maintains smaller-scale gold and silver operations in Mexico that provide supplementary revenue streams and diversification of its mineral portfolio.

Founded in the mid-20th century, United States Antimony has evolved from a single‐mine operator into a multinational enterprise with mining and processing sites in both the United States and Mexico.